Norges Bank’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-153,492
| Closed | -$16.5M | – | 2136 |
|
|
2023
Q1 | $16.5M | Buy |
153,492
+90,992
| +146% | +$9.77M | ﹤0.01% | 1364 |
|
|
2022
Q4 | $6.88M | Buy |
+62,500
| New | +$6.88M | ﹤0.01% | 1684 |
|
|
2022
Q3 | – | Sell |
-488,745
| Closed | -$13.8M | – | 2148 |
|
|
2022
Q2 | $13.8M | Sell |
488,745
-399,244
| -45% | -$11.3M | ﹤0.01% | 1414 |
|
|
2022
Q1 | $33.5M | Buy |
887,989
+282,545
| +47% | +$10.7M | 0.01% | 1100 |
|
|
2021
Q4 | $23.9M | Buy |
605,444
+213,492
| +54% | +$8.44M | ﹤0.01% | 1378 |
|
|
2021
Q3 | $9.29M | Hold |
391,952
| – | – | ﹤0.01% | 1790 |
|
|
2021
Q2 | $9.63M | Hold |
391,952
| – | – | ﹤0.01% | 1793 |
|
|
2021
Q1 | $7.16M | Buy |
+391,952
| New | +$7.16M | ﹤0.01% | 1861 |
|